2024 NHLBI Workshop Charts Promising Future Directions for ECMO-Induced Coagulopathy
Jerrold Levy, MD, Critical care physician in CTICU, Duke University School of Medicine, recently shared an insightful post on X:
”ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (workshop NHLBI report). This open access 2024 summary is online and new ASH journal (BLOODVTH) not on PubMED yet. Extracorporeal Life Support Organization (ELSO) please share with your community.”
Read the full article here.
The NHLBI hosted a May 2024 workshop on ECMO-induced coagulopathy, uniting experts to tackle anticoagulation challenges and advance precision medicine approaches.
The event highlighted research gaps, innovative therapies, and opportunities for interdisciplinary collaboration to improve patient outcomes.
More news on scientific advancements in Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp